Search

Erick Giang

from San Diego, CA
Age ~42

Erick Giang Phones & Addresses

  • 7261 Hamlet Ct, San Diego, CA 92120
  • La Jolla, CA
  • San Gabriel, CA
  • 10170 Camino Ruiz UNIT 39, San Diego, CA 92126

Work

Company: The scripps research institute Position: Research assistant

Education

Degree: B.S. School / High School: University of California, San Diego 2000 to 2004 Specialities: Biology

Languages

English

Industries

Research

Resumes

Resumes

Erick Giang Photo 1

Research Assistant

View page
Location:
7261 Hamlet Ct, San Diego, CA 92120
Industry:
Research
Work:
The Scripps Research Institute
Research Assistant
Education:
University of California, San Diego 2000 - 2004
B.S., Biology
Languages:
English

Publications

Us Patents

Engineered Hcv E2 Immunogens And Related Vaccine Compositions

View page
US Patent:
20230034467, Feb 2, 2023
Filed:
Dec 17, 2021
Appl. No.:
17/554907
Inventors:
- La Jolla CA, US
Jiang Zhu - San Diego CA, US
Erick Giang - San Diego CA, US
Mansun Law - San Diego CA, US
Ian Wilson - La Jolla CA, US
Netanel Tzarum - Jerusalem, IL
International Classification:
C07K 14/005
C12N 7/00
A61K 39/29
A61P 31/14
A61K 47/69
Abstract:
The present invention provides novel engineered HCV E2 polypeptide immunogens and related vaccine compositions that display the engineered E2 polypeptides. The invention also provides methods of using such immunogens and vaccine compositions in various therapeutic applications, e.g., for preventing or treating HCV infections.

Engineered Hcv E2 Immunogens And Related Vaccine Compositions

View page
US Patent:
20210024585, Jan 28, 2021
Filed:
Jul 24, 2020
Appl. No.:
16/938105
Inventors:
- La Jolla CA, US
Jiang Zhu - San Diego CA, US
Erick Giang - San Diego CA, US
Mansun Law - San Diego CA, US
Ian Wilson - La Jolla CA, US
Netanel Tzarum - Jerusalem, IL
International Classification:
C07K 14/005
C12N 7/00
A61K 39/29
A61K 47/69
A61P 31/14
Abstract:
The present invention provides novel engineered HCV E2 polypeptide immunogens and related vaccine compositions that display the engineered E2 polypeptides. The invention also provides methods of using such immunogens and vaccine compositions in various therapeutic applications, e.g., for preventing or treating HCV infections.
Erick Giang from San Diego, CA, age ~42 Get Report